ROXRO Announces FDA Approval Of SPRIX(TM)

Links shared publicly online about this topic.

  • 1,143
    total visits

ROXRO Announces FDA Approval Of SPRIX(TM)

medicalnewstoday.com

ROXRO PHARMA, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute

View full resource at medicalnewstoday.com

Tags: Pain, Nose, Drug, Pharma, FDA, NSAIDs, Toradol

  • Share

Most Recently Shared on May 25, 2010 at 2:10 pm By:

Also Shared By:

MNT Pharma News MNT Pharma News

MNT Pain News MNT Pain News

Roxro Announces FDA Approval of Sprix

drugs.com — “Sprix (ketorolac tromethamine) is used to treat pain. Includes Sprix side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on May 17, 2010 at 11:32 pm By:

ROXRO Announces FDA Approval of SPRIX - FiercePharma

fiercepharma.com — “ROXRO Announces FDA Approval of SPRIX (Ketorolac Tromethamine) - First Non-narcotic Intranasal Analgesic for Moderate to Moderately Severe Pain - Download image MENLO PARK, Calif., May 17... Read more...View full resource at fiercepharma.com

  • View Related
  • Share

Most Recently Shared on May 17, 2010 at 6:38 pm By:

FDA approves ROXRO PHARMA's SPRIX Nasal Spray

news-medical.net — “ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX" (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 17, 2010 at 5:47 pm By:

Stroke_News News-Medical.Net Health News

Stroke News: FDA approves ROXRO PHARMA's SPRIX Nasal Spray: ROXRO PHARMA, Inc. announced today that the U.S. Foo... http://twurl.nl/jp5kc1

2 years ago...

Advertisement